Home Biosimilar Antibodies Protein Tyrosine Kinase Others antibody Cofetuzumab (Anti-PTK7 / CCK4) For research use only.
Not for use in humans.

Cofetuzumab (Anti-PTK7 / CCK4)

Synonyms:

Cofetuzumab (Anti-PTK7 / CCK4) is humanized IgG1 monoclonal antibody against protein tyrosine kinase 7 (PTK7) with potential antitumor activity. MW : 146.7 KD.

Cofetuzumab (Anti-PTK7 / CCK4)

Purity & Quality Control

Batch: A280301 Purity: 99% Protein concentration: 6.05mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Cofetuzumab (Anti-PTK7 / CCK4) is humanized IgG1 monoclonal antibody against protein tyrosine kinase 7 (PTK7) with potential antitumor activity. MW : 146.7 KD.

Product Details

CAS No. 1869928-62-0
Molecular Weight 146.7
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Cofetuzumab (Anti-PTK7 / CCK4) | Cofetuzumab (Anti-PTK7 / CCK4) supplier | purchase Cofetuzumab (Anti-PTK7 / CCK4) | Cofetuzumab (Anti-PTK7 / CCK4) cost | Cofetuzumab (Anti-PTK7 / CCK4) manufacturer | order Cofetuzumab (Anti-PTK7 / CCK4) | Cofetuzumab (Anti-PTK7 / CCK4) distributor